Contains: Resource

Fixing a Broken System: The Path to Public Pharma in New York

6 Oct 2025, 11 p.m. in Action & Workshop, Contains: Resource, Country: United States, Taking on Monopoly Power: Public Pharma by T1International

On Thursday, September 25, 2025, T1International brought policy leaders, advocates, and patients together at NYU Law for “Fixing a Broken System: The Path to Public Pharma in New York,” a major public event highlighting the urgent need for publicly controlled pharmaceutical production to counter skyrocketing drug prices. Read more

Findings from T1International's 2024 Out-of-Pocket Expenses and Rationing Survey

28 May 2025, 4:15 p.m. in Contains: Resource, Content Type: News & Statements, Country: Panama, Country: United States, Research by T1International

Make it Right: The Fight for Insulin Access on World Diabetes Day

20 Nov 2024, 6:19 p.m. in Action & Workshop, Contains: Resource, Country: South Africa, Insulin Access: Modern Insulins by Shaina Kasper

On World Diabetes Day, we shine a spotlight on a glaring injustice: millions of people with diabetes in low- and middle-income countries are denied access to affordable insulin pens—a delivery method that could save and transform lives. Pharmaceutical giants Eli Lilly, Novo Nordisk, and Sanofi have monopolized the diabetes market, prioritizing profit over people. It’s time to demand change. It’s time to make it right. Read more

Three Reasons Why is Insulin STILL So Expensive

29 Aug 2023, 4:49 p.m. in Contains: Resource, Country: Global, Insulin Access: Alec's Law, Insulin Access: Kevin's Law, Insulin Access: Modern Insulins, Insulin Access: Price Caps, Taking on Monopoly Power: Patent Reform, Taking on Monopoly Power: Public Pharma by Shaina Kasper

Over the past few months, many insulin manufacturers and other entities have announced that they will be lowering the price of insulin in the United States. So, why is insulin still so expensive?
We recently released our Policy Playbook that goes through all of the details and gives advocates the information to push for change locally and nationally. Why insulin is so expensive can be boiled down to three main points. Read more